Characterization of Bucolome N-Glucuronide Formation: Tissue Specificity and Identification of Rat UDP-Glucuronosyltransferase Isoform (s)
- 1
- 2
- 3
- 4 Clinical Pharmaceutics Laboratory, Department of Pharmacy and Health Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Meiji Pharmaceutical University 2-522-1 Noshio, Kiyose-shi, Tokyo 205-8555, Japan
Abstract
Bucolome N-glucuronide (BCP-NG, main metabolite of bucolome (BCP) is the first N-glucuronide of barbituric acid derivatives isolated from rat bile. The objective of this study was to identify the main tissue producing BCP-NG and the molecular species of BCP-NG-producing UGT. Four target tissues were investigated: the liver, small and large intestines, and kidney. To identify the UGT molecular species responsible for BCP-NG formation, yeast microsomes expressing each rat UGT isoform were prepared. BCP-NG formation was detected in all microsomal fractions of the 4 tissues. The liver microsomal BCP-NG-producing activity was the highest, followed by that in the small intestinal microsomes, showing about 41% of the liver microsomal activity level. BCP-NG-producing activity (min-1) was determined in yeast microsomal fractions expressing rat UGT isoforms, and the activity was detected in UGT1A1 (0.059), UGT1A2 (0.318), UGT1A3 (0.001), UGT1A7 (0.003), UGT2B1 (0.004), UGT2B3 (0.091), and UGT2B6 (0.031), showing particularly high levels for UGT1A1 and UGT1A2 among the UGT1A isoforms. It was clarified that UGT1A1, widely distributed in rat tissues, is the molecular species responsible for BCP-NG formation.
- S. Senda, H. Izumi, and H. Fujimura, “On uracil deriva- tives and related compounds. 6, 5-alkyl-2,4,6-trioxo-per- hydrophyrimidine derivatives as antiphlogistics,” Arznei- mittelforschung; vol. 17, no.12, December 1967, pp. 1519-1523.
- N. Takamura , T. maruyama, E. Chosa, K. Kawai, Y. Tsutsumi, Y. Uryu, K. Yamasaki, T. Deguchi, and M. Otagiri, “Bucolome, a potent binding inhibitor for fu- rosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome,” Drug Metabo- lism and Disposition,vol. 33, no. 4, April 2005, pp. 596- 602.
- M. Osawa, N. Hada, K. Matsumoto, T. Hasegawa, D. Kobayashi, Y. Morimoto, M. Yamaguchi, I. Kanamoto, T. Nakagawa, and K. Sugibayashi, “Usefulness of coadmin- istration of bucolome in warfarin therapy: pharmacoki- netic and pharmacodynamic analysis using outpatient prescriptions,” Internal Journal of Pharmaceutics, vol. 293, no. 1-2, April 2005, pp. 43-49.
- M. Kobayashi, M. Takagi, K. Fukumoto, R. Kato, K. Tanaka, and K.Ueno, “The effect of bucolome, a CYP2C9 inhibitor, on the pharmacokinetics of losartan,” Drug Metabolism and Disposition, vol. 23, no. 2, 2008, pp. 115-119.
- B. K. Tang, W. Kalow, and A. A. Grey, “Metabolic Fate of Phenobarbital in man N-Glucoside Formation,” Drug Metabolism and Disposition, vol. 5, no. 5, September- October, 1979, pp. 315-318.
- B. K. Tang, W. Kalow, and A.A. Grey, “Amobarbital metabolism in man: N-glucoside formation,”Research communications in chemical pathology and pharmacol- ogy, vol. 21, no. 1, July, 1978, 45-53.
- S. M. Neighbors, and W. H. Soine, “Identification of Phenobarbital N-glucuronides as urinary metabolites of Phenobarbital in mice,” Drug Metabolism and Disposi- tion, vol. 23, no. 5, May, 1995, pp. 548-552.
- K. Mohri, T. Uesugi, and K. Kamisaka, “Bucolome N- glucuronide: purification and identification of a major metabolite of bucolome in rat bile,” Xenobiotica, vol. 15, no. 7, July, 1985, pp. 615-621.
- K. Mohri, and Y. Uesawa, “Enzymatic Activities in the Microsomes Prepareted from Rat Small Intestinal Epithelial Cells by Differential Procedures,” Pharmaceutical Research, vol. 18, no. 8, Augasut, 2001, pp. 1232-1236.
- O. H. Lowry, N .J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the folin phenol reagent,” Journal of Biological Chemistry, vol. 1, no. 1, November, 1951; pp. 265-275.
- P. K. Smith, R. I. Krohn, G.T. Hermanson, A. K. Malliam F. H. Garther, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk, “Measurement of protein using bicinchoninic acid,” Analitycal Biochemistry, vol. 150, no. 1, October, 1985, pp. 76-85.